apoptotic and necrotic stages. The cells were pre-treated for 2 h with 50 μM Z-VAD(OMe)-FMK, then incubated with the complexes in the established concentration (2.5 μM for complex 1 and 5 μM for complex 2) for 48 h. The negative control (CTL) was treated with the vehicle (0.1% of a solution containing 70% sorbitol, 25% tween 80 and 5% water) used for diluting the compounds tested. Oxaliplatin (OXA, 3 μM) and piplartine (PL, 10 μM) were used as the positive controls. Ten thousand events were evaluated per experiment and cellular debris was omitted from the analysis. 
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